Publications by authors named "Navin Amarasinghe"
Article Synopsis
- COVID-19 can lead to an increased risk of myasthenic crisis, particularly in patients with myasthenia gravis, as seen in a case involving an 86-year-old male who deteriorated despite treatment.
- Dexamethasone, while effective for severe COVID-19, may worsen myasthenia gravis symptoms when given in high doses, highlighting the risks involved in managing such patients.
- Ongoing monitoring of respiratory function and further research are necessary to understand the impact of steroid treatment in those with myasthenia gravis diagnosed with COVID-19.
